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Summary  
The Burkholderia cepacia complex (Bcc) is a group of Gram-negative opportunistic 
pathogens causing infections in people with cystic fibrosis (CF). Bcc are highly 
antibiotic resistant, making conventional antibiotic treatment problematic. The 
identification of novel targets for anti-virulence therapies should improve therapeutic 
options for infected CF patients. We previously identified that the peptidoglycan-
associated lipoprotein (Pal) was immunogenic in Bcc infected CF patients; however, 
its role in Bcc pathogenesis is unknown. The virulence of a pal deletion mutant (Δpal) 
in Galleria mellonella was 88-fold reduced (p<0.001) compared to wild-type. The 
lipopolysaccharide profiles of wild-type and Δpal were identical, indicating no 
involvement of Pal in O-antigen transport. However, Δpal was more susceptible to 
polymyxin B. Structural elucidation by X-ray crystallography and calorimetry 
demonstrated that Pal binds peptidoglycan fragments. Δpal showed a 1.5-fold reduced 
stimulation of IL-8 in CF epithelial cells relative to wild-type (p<0.001), 
demonstrating that Pal is a significant driver of inflammation. The Δpal mutant had 
reduced binding to CFBE41o- cells, but adhesion of Pal-expressing recombinant E. 
coli to CFBE41o- cells was enhanced compared to wild-type E. coli, confirming that 
Pal plays a direct role in host cell attachment. Overall, Bcc Pal mediates host cell 
attachment and stimulation of cytokine secretion, contributing to Bcc pathogenesis. 
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Introduction		
The Burkholderia cepacia complex (Bcc) is a group of closely related Gram-negative 
bacteria causing opportunistic chronic infections in people with cystic fibrosis (CF). 
The complex currently comprises 20 species, the majority of which are highly 
resistant to different classes of antibiotics (Peeters et al., 2013, De Smet et al., 2015). 
While all species can potentially cause airway infections in people with CF, the most 
clinically relevant are B. multivorans and B. cenocepacia (Drevinek and 
Mahenthiralingam, 2010). Further, a subset of CF patients infected with Bcc can 
develop an aggressive infection with septicaemia and rapid decline in lung function, 
referred to as cepacia syndrome (Isles et al., 1984). Since Bcc bacteria are highly 
resistant to most clinically used antibiotics there is a need for alternative therapies. 
Identifying, understanding, and targeting specific virulence determinants may unravel 
novel means to control Bcc infection.   
We have recently identified immunoreactive proteins expressed by B. cenocepacia 
and B. multivorans during human infection using an immunoproteomics approach 
(Shinoy et al., 2013). The peptidoglycan-associated lipoprotein (Pal, GI:357936457), 
encoded by BCAL3204 was among the immunogenic proteins that were consistently 
identified in B. multivorans and B. cenocepacia. Pal from both species generated 
pronounced antibody responses in Bcc infected patients. Lipoproteins play roles in the 
pathogenesis of various bacterial species (McClean, 2012), as they are involved in 
signal transduction, conjugation and nutrient uptake, and also play a role in antibiotic 
resistance, transport, and extra-cytoplasmic folding of proteins. Lipoproteins also 
facilitate bacterial adhesion, invasion, colonization, immunomodulation and evasion 
of host defence, as recently reviewed (Kovacs-Simon et al., 2011). For example, a 
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reduction in fibronectin and laminin binding was demonstrated for Streptococcus 
pyogenes Lsp mutants that were defective in lipoprotein release, with the mutant 
showing reduced levels of adhesion and internalization (Elsner et al., 2002). 
Lipoproteins were also classed as pathogen-associated molecular patterns (PAMPs) 
which play a role in modulating the host immune response and are recognized by 
TLR-2 receptors (Godlewska et al., 2009). Pal is a component of the Tol/Pal complex 
and the genes encoding Tol and Pal proteins comprise two adjacent operons in E. coli 
and in other bacterial species. The Tol/Pal complex is required for maintaining cell 
wall integrity (Lazzaroni et al., 1999, Rodriguez-Herva et al., 1996) and for regulation 
and co-ordination of outer-membrane invagination during cell constriction in E. coli 
(Gray et al., 2015, Gerding et al., 2007). Tol/Pal proteins play a role in the transport 
of LPS subunits, including the O-antigen region, to the outer membrane (Vines et al., 
2005, Gaspar et al., 2000). Pal expressed by Gram-negative bacteria possesses a 
region with conserved surface residues that forms a binding pocket for the meso-
diaminopimelate (m-DAP) residue of peptidoglycan (Parsons et al., 2006). Pal is 
anchored in the outer membrane and interacts independently with OmpA and Lpp 
envelope proteins (Godlewska et al., 2009). Recently, it was shown that between 10 to 
20% of E. coli cells express Pal on their surface (Michel et al., 2015). The non-
typeable Haemophilus influenzae Pal homologue P6 also has a dual orientation, being 
exposed infrequently on the surface, but predominantly oriented towards the 
periplasmic space (Michel et al., 2013). Pal can be secreted into the extracellular 
environment or the bloodstream during infection, contributing to septic shock 
(Hellman et al., 2002). E. coli Pal is released into human serum in tight association 
with LPS, inducing TLR2-mediated cytokine production by macrophages. Pal and 
LPS synergistically activate macrophages indicating that Pal may play an important 
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role in inflammation and the pathogenesis of sepsis (Liang et al., 2005). Despite 
considerable studies in other organisms, the role of Pal in Bcc pathogenesis was not 
investigated previously. The strong anti-Pal immunogenic response in Bcc colonised 
CF patients (Shinoy et al., 2013) demonstrates that the protein interacts with the 
human immune system and suggests a role in pathogenesis. Here, we demonstrate that 
Bcc Pal is structurally similar to E. coli Pal, possessing the conserved peptidoglycan-
binding site. We also developed a targeted Pal deletion mutant in B. cenocepacia and 
show that Pal plays a role in virulence in an acute infection model, it is a potent driver 
of IL-8 secretion, and mediates adhesion to lung epithelial cells. 
 
 
RESULTS  
 
Pal is required for pathogenicity in the Galleria mellonella infection model  
The Δpal mutant and B. cenocepacia K56-2 wild-type strains had comparable growth 
curves in LB with doubling times of 80 and 90 min respectively.  To investigate if Pal 
has a role in virulence, the survival of the G. mellonella larvae was evaluated 
following infection with the Δpal deletion mutant in comparison with K56-2. While 
K56-2 was highly lethal to G. mellonella (LD50 of 1.66 + 1.91 at 48 h), Δpal 
demonstrated substantially attenuated virulence (88-fold increase in LD50 of 145.5 + 
6; p<0.001). The virulence phenotype was partially complemented when the pal gene 
was encoded on a pDA-12 plasmid (LD50 of 40 + 5.7) suggesting that the virulence 
phenotype may be gene dosage dependent and highlights the complexity of virulence 
in this model. Purified recombinant PalBc did not affect larval survival, with 100% of 
larvae surviving after 72 h exposure to up to 3 µg (maximum dose allowable based on 
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injection volume) of purified recombinant protein, indicating that this amount of pure 
Pal is not toxic to the larvae. 
 
Larvae injected with cell free supernatant (CFS) from Δpal showed reduced survival 
(60% survival at 72 h) relative to those injected with CFS from wild-type (80% 
survival at 72 h), (P<0.0001) (Fig. 1). When pal gene expression was reconstituted 
chromosomally in the Δpal mutant, the CFS from complemented Δpal(pal+) strain did 
not affect survival at 72 h. We conclude that this phenotype reflects impaired outer 
membrane integrity of Δpal, which allows release of periplasmic proteins and outer 
membrane vesicles to the external milieu contributing to the enhanced toxicity of the 
supernatant fraction from this strain. Impaired outer membrane integrity was 
confirmed by measuring the uptake of the fluorescent dye H33342. A 1.4-fold 
difference in dye uptake was apparent within 30 min by the Δpal mutant over wild-
type K56-2 cells, while this difference disappeared in the  complemented Δpal(pal+) 
strain and this was sustained for over 90 min (P<0.0001, Fig. 1C). 
  
Pal does not affect LPS phenotype, but is involved in polymyxin resistance  
LPS was isolated from wild-type and mutant strains to assess if the Δpal mutant had a 
defect in O-antigen expression. Comparison of LPS extracts from mutant and wild-
type on 15 % acrylamide gels showed no discernible difference in the LPS 
electrophoretotypes between the Δpal mutant and wild-type K56-2 (Fig. 2A). This 
was confirmed by mass spectrometry of the lipid A from wild-type K56-2 and the 
Δpal mutant (Fig. 2B) and indicates that the decreased virulence of the mutant was 
independent of LPS composition. As polymyxin B targets LPS components, the 
sensitivity of Δpal to polymyxin B was also examined. Wild-type K56-2 was highly 
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resistant to polymyxin B on Mueller Hinton agar (MIC 96 µg/ml), but Δpal was three-
fold more sensitive (MIC of 32 µg/ml) (Fig. S1). Polymyxin B resistance was restored 
in the complemented strain Δpal(pal+), confirming that polymyxin susceptibility was 
due to the loss of Pal. These results suggest that despite the lack of apparent 
differences in LPS the Δpal mutant has compromised outer membrane permeability.     
In comparison, there was no difference in susceptibility to either levofloxacin (not 
shown) or meropenem between the wild-type and Δpal mutant (Fig. S1).   
 
B. cenocepacia Pal is a lipoprotein with a conserved peptidoglycan-binding site   
B. cenocepacia Pal (PalBc) is a predicted lipoprotein. Consistent with this, its 
sequence has a hydrophobic N-terminal lipoprotein signal peptide followed by the 
LAAC lipobox motif, consistent with proteolytic processing by signal peptidase II 
during translocation across the cytoplasmic membrane (cleavage site between LAA-
C, Fig. 3A). Electron spray MS analysis of purified His-tag PalBc showed it has a 
mass of 22820 +5 Da, equivalent to the theoretical mass of PalBc with poly-His and 
the Xpress epitope (Fig. S2, S3). PalBc  co-purifies with acylated forms, with masses 
consistent with the palmitoylated (23520 Da), myristoylated (23460 Da) and 
laurylated forms (23408 Da) all having a DAP residue (190.2). These were identified 
in the spectrum with relative abundances as determined by peak height ratios of 
5:1:1:0.5 (Fig. S3). This is consistent with the recombinant PalBc being lipidated at the 
lipobox in the E. coli BL21Star cells and is expressed as a lipoprotein.   
 
As predicted by the Pfam database, PalBc also contains an OmpA domain (Fig. 3). 
Based on these analyses and on secondary structure predictions, we cloned and 
expressed a truncated form of Pal containing residues 51 to 170 (Pal51-170), which was 
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amenable to crystallization. Pal51-170 was monomeric in solution, as evidenced by both 
size exclusion chromatography and dynamic light scattering (Fig. 3B and C). Circular 
dichroism spectra show that Pal51-170 adopts a α-β-conformation (Fig. 3D). Also, 
thermal unfolding curves, achieved by following the CD signal at 222 nm as a 
function of temperature, indicate a stable structure, with melting temperature 
Tm=48°C (Fig. 3E).  Crystals of Pal51-170 suitable for X-ray diffraction were obtained 
using vapour diffusion techniques and belonged to the hexagonal space group P32. 
The structure was solved by molecular replacement and refined at 2.0 Å (Table 3). 
The structure includes two molecules in the asymmetric unit, with close structural 
similarity (r.m.s.d. 0.2 Å upon superposition of Cα atoms 52-170). Consistent with 
CD data, the overall structure of each molecule showed a α-β sandwich fold, 
organized in a helix-strand-helix topology (Fig. 4A). The analysis of the protein 
surface revealed a deep cavity (located close to the N-terminal ends of the α-helix α2) 
whose rear wall is contributed by the side chain of Arg120 (Fig. 4B). Surface 
conservation computation, carried out with ConSurf (Goldenberg et al., 2009), 
showed that the residues forming the cavity, namely Asp-71, Asp-105, Gly-106, Tyr-
112, Asn-113, Arg-120, are highly conserved (Fig. 4C). This conservation indicates a 
functional role for this surface region and agrees with the finding that mutants of Asp-
197 and Arg-217 in the OmpA-like MotB of E. coli (corresponding to Asp-105 and 
Arg-120 in Pal51-170, respectively) are non-functional in vivo (Blair et al., 1991).   
 
Analysis of electron density maps showed density blobs which were not associated 
with protein residues in the Pal51-170 crystals and not compatible with any molecules 
from the crystallization medium. This density was interpreted as belonging to a 
muropeptide fragment; probably a fragment of the E. coli peptidoglycan bound to the 
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protein upon lysis and carried through the purification process. Likely, Pal51-170 
recognizes common features between its physiological substrate in B. cenocepacia 
and a muropeptide of E. coli, as both species produce DAP-type peptidoglycan. Based 
on the shape and size of electron density, a DAP molecule was built in each cavity of 
the two molecules in the asymmetric unit (Fig. 4D). In each molecule, DAP is deeply 
immersed in the identified cavity (Fig. S4) having its carboxylate engaging the 
guanidinium group of Arg-120 in a bidentate salt bridge. This carboxylate also forms 
hydrogen bonds to the main-chain amide protons of Asp-105. Nζ of DAP is H-
bonded to the side chain of Asp-105 and the main chain carbonyl oxygen of Arg-106 
(Fig. 4D). Hydrophobic interactions also involve Phe-72 and Arg-106, Leu-116, all 
highly conserved residues. The maps show further density, not interpretable likely due 
to high flexibility of the bound muropeptide. The binding mode of DAP to Pal51-170 
resembles that of OmpA of E. coli (Park et al., 2012), with a similar structural 
organization of interacting residues (Fig. S5).  
 
The ability of Pal51-170 to bind muropeptides was confirmed by Isothermal Titration 
Calorimetry (ITC) (Fig. 5 A and B). Binding isotherms for the interaction of Pal51-170 
with the muropeptide fragment (iE-DAP, measured at pH 7.5) were characterized by 
exothermic heats of binding which decreased in magnitude with successive injections 
of ligand until saturation was achieved.  These data indicate a moderate protein-ligand 
binding affinity, with KD of 27.4 (±7.4) µM and ΔH of 4.3 (±0.4) Kcal/mol, 
respectively. 
   
PalBc stimulates a potent pro-inflammatory response   
We previously showed that Pal expressed by B. multivorans and B. cenocepacia 
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stimulate a strong antibody response in infected CF patients (Shinoy et al., 2013). To 
determine if Pal also contributes to pro-inflammatory responses, we examined the 
secretion of cytokines from CF lung epithelial cells (CFBE41o-) after infection with 
Δpal or wild-type K56-2 strains. While infection with K56-2 strain induced potent 
stimulation of IL-8 and IL-6 secretion, infection with Δpal resulted in reduced IL-8 
secretion (1.5-fold, p<0.001) with no difference in IL-6 secretion (Fig. 6). These 
results indicate Pal contributes to IL-8 stimulation, as expected from a lipoprotein. 
Weak but comparable secretion of IL-4 and Interferon-γ were observed for wild-type 
and mutant strains, and no differences were found in the secretion of IL-10, IL12p70, 
IL-13, IL-1β, IL-2 or TNFα. Secretion of IL-8 by CFBE41o- cells exposed to purified, 
endotoxin-free PalBc increased in a concentration dependent manner, in comparison to 
the medium control samples (Fig. 6C), confirming that the observed reduced secretion 
of IL-8 following infection with the Δpal mutant was a direct effect of the absence of 
Pal. Indeed, 50 µg/ml PalBc, stimulated comparable levels of IL-8 relative to the levels 
from cells incubated with purified LPS (100 µg/ml) from B. cenocepacia K56-2 (Fig. 
6C), highlighting the potency of PalBc in the chemokine response.  Although the Δpal 
mutant did not alter IL-6 secretion, the levels of this cytokine increased 3-fold in 
response to 100 µg/ml PalBc compared to the MEM control (Fig. 6D). PalBc was not as 
effective in stimulation of IL-6 secretion relative to LPS at the same concentration 
(100 µg/ml), PalBc induced IL-6 levels of 285 pg/ml for PalBc compared with 516 
pg/ml for LPS. PalBc did not stimulate secretion of any other cytokines in the panel, 
IFNγ, IL-10, IL12p70, IL-13, IL-1β, IL-2,  IL-4 or TNFα,  at concentrations up to 100 
µg/ml.     
 
Pal is involved in attachment to human lung epithelial cells.  
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The attachment of bacteria to host cells is an important step in the colonization 
process and many immunogenic proteins stimulate the host response via direct 
interaction with the host epithelium. The C-terminus of Pal shares homology with 
OmpA proteins which were associated with the host cell attachment of several 
pathogens (McClean, 2012). The attachment of the Δpal mutant to CFBE41o- lung 
epithelial cells was compared to the wild-type K56-2 strain to determine if Pal is 
involved in the attachment of Bcc to lung cells. We used two independent methods, 
cell lysis and subsequent plating to determine the CFU/ml attached and confocal 
microscopy. There was a 2.5-fold reduction in binding of the Δpal mutant relative to 
K56-2 cells (p=0.0189), with host cell attachment being reduced to that of the 
negative control, E. coli strain NCIB9485. This was confirmed by confocal 
immunofluorescence microscopy, which showed a 34% reduction in attachment of the 
Δpal mutant relative to wild-type K56-2 (Fig. 7, p=0.0462). Adhesion was restored to 
wild-type levels in the Δpal(pal+) complemented strain (Fig. 7).   
 
To further evaluate the role of Pal in host cell attachment and to investigate whether 
the protein plays a direct role in cellular attachment recombinant E. coli BL21 cells 
expressing PalBc under β-D-1-thiogalactopyranoside (IPTG) induction (Kim et al., 
2010, Plesa et al., 2004) were examined for their ability to bind to CFBE41o- cells, 
relative to E. coli BL21 cells and again quantified using confocal microscopy (Fig. 
8A).  E. coli BL21 cells bind poorly to CFBE41o- cells, as expected, with two bacteria 
being attached per 100 epithelial cells (Fig. 8B).  Attachment of BL21 cells induced 
to express PalBc showed an increase in attachment to CFBE41o- cells relative to 
control BL21 cells (p<0.0001), suggesting that Pal interacts directly with the lung 
epithelial cells, rather than indirectly being involved in attachment via regulation of 
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other proteins.   
Discussion   
The Tol/Pal system was extensively studied in E. coli and is associated with various 
physiological processes in E. coli including cell wall integrity and constriction of the 
outer membrane. The Pal C-terminus also shares high homology with OmpA, which 
is associated with host cell attachment of many pathogens (McClean, 2012, De Mot 
and Vanderleyden, 1994). TolB and Pal are poorly conserved proteins, although 
ubiquitous across Gram-negative organisms; however, they are conserved among Bcc 
species (Plesa et al., 2004). Pal is essential for survival and pathogenesis in other 
bacteria, although its role in virulence was not clearly defined (Godlewska et al., 
2009). We have previously shown that Pal is immunogenic in Bcc colonised CF 
patients (Shinoy et al., 2013), but little was know about the role of Pal in Bcc. In this 
study, we have demonstrated that the Pal protein from B. cenocepacia plays a role in 
virulence and mediates host cell attachment. In addition, we have demonstrated that 
PalBc stimulates IL-8 secretion.  
The crystal structure of the OmpA-like domain of PalBc revealed strong 
structural similarities with Pal proteins from B. pseudomallei and E. coli, which form 
a characteristic α-β sandwich fold (Gourlay et al., 2013). Further, the PalBc structure 
confirmed its potential to bind peptidoglycan, consistent with the conservation of 
specific residues that contribute to a deep cavity where the DAP moiety is located. It 
is likely that peptidoglycan binding plays an important role in anchoring of the outer 
membrane to the bacterial cell wall and contributing to maintain cell envelope 
integrity (Park et al., 2012) and may also limit the lateral diffusion of OmpA proteins 
in outer membranes (Verhoeven et al., 2013, Winther et al., 2009). 
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Mutations defective in Tol/Pal proteins are not always lethal suggesting that 
other outer membrane proteins may act as substitutes (Godlewska et al., 2009).  
Mutations typically result in hypersensitivity to detergents and/or antibiotics 
(Cascales et al., 2002) and disruption of cell-envelope integrity (Rodriguez-Herva et 
al., 1996), suggesting a role for these proteins in maintaining structure and function of 
the cell envelope. Consistent with this notion, PalBc also has a role in maintaining 
membrane integrity as determined by the increase in permeability to H33342. In 
addition the enhanced lethality of cell free supernatant from the Bcc Δpal strain to G. 
mellonella compared with WT is also suggestive of release of virulence factors and/or 
inflammatory mediators in the mutant. Further, the enhanced sensitivity of Δpal to the 
membrane-acting antibiotic polymyxin also denotes enhanced outer membrane 
permeability. Polymyxin	 binds	 to	 LPS,	 allowing	 its	 hydrophobic	 tail	 to	 disrupt	both	bacterial	membranes.	Given	that	the	permeability	of	the	mutant	is	impaired	due	to	the	lack	of	Pal,	it	is	reasonable	to	assume	the	mutant	would	also	be	more	susceptible	 to	 the	 detergent	 action	 of	 the	 hydrophobic	 tail.	 In	 contrast,	 no	alteration	 in	 meropenem	 susceptibility	 was	 observed.	 This	 is	 expected,	 as	meropenem	 inhibits	 peptidoglycan	 synthesis	 and	 although	 Pal	 binds	 to	peptidoglycan,	 the	 synthesis	 of	 the	 peptidoglycan	 layer	 should	 remain	unimpaired	in	the	Pal	mutant	and	consequently	both	mutant	and	wild-type	show	similar	 susceptibilities.	 Despite reports that the Tol/Pal system has a role in the 
biogenesis and transport of LPS components in E. coli (Gaspar et al., 2000, Vines et 
al., 2005), PalBc does not appear to be required for LPS transport, as the Δpal mutant 
and wild-type showed comparable LPS profiles. Given the high degree of modularity 
that exists in Tol/Pal complex, it is plausible that those individual components in the 
complex are replaced across evolution and that functional roles associated with one 
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member of the complex in a bacterial species, may be carried out by another member 
of the Tol/Pal complex in other bacteria.    
OmpA-like proteins were associated with a variety of virulence factors 
(Prasadarao et al., 1996, Sukumaran et al., 2003, Torres and Kaper, 2003).  Consistent 
with these studies, we have shown that the Pal mutant reduced virulence in G. 
mellonella by 88-fold. It is still unknown how Bcc kills the larvae; however, it was 
shown that virulence in G. mellonella correlates well with survival of Bcc infected 
mice (Seed and Dennis, 2008). It is difficult to postulate how Pal may play a role in 
larval death, but the progress of infection was accompanied by increased 
melanisation, which is indicative of larval immune response. Lethality may be due to 
an overwhelming immune response to infection, and related to the potency of Pal in 
stimulating pro-inflammatory response in epithelial cells.  Exposure of CF cells to the 
Δpal mutant showed that PalBc is a potent stimulator of the IL-8 chemokine. 
Considering all the potential PAMPs expressed on the surface of the wild-type strain 
K56-2 (LPS, flagellin, outer membrane proteins, other lipoproteins) (Hanuszkiewicz 
et al., 2014, Ortega et al., 2005), the fact that the Δpal mutant reduces IL-8 secretion 
by 33% demonstrates Pal is a key driver of Bcc-induced IL-8 secretion in CF lung 
epithelial cells. IL-8 stimulation was confirmed with PalBc, which stimulated 
comparable levels of IL-8 to LPS. IL-8 is a chemotactic cytokine and is particularly 
important in CF as inflammation is a neutrophil-dominated process in the CF lung. 
The substantially impaired IL-8 secretion elicited by the Δpal mutant indicates that 
Pal is a significant contributor to the overall inflammatory response in the CF lung.  
PalBc also stimulated IL-6 secretion, albeit to a lesser degree than IL-8. The Δpal 
mutant did not have any impact on IL-6 secretion of the K56-2 strain, highlighting 
that while Pal can stimulate IL-6 secretion, other PAMPs in B. cenocepacia are more 
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predominant stimulators of IL-6 and the absence of Pal in the mutant was 
compensated for by other PAMPs.  Despite that Pal, consistent with other bacterial 
lipoproteins, most likely activates TLR2 (Zhu et al., 2007, Liang et al., 2005, 
Berenson et al., 2005), we used LPS, a TLR-4 activator, as a positive control, as we 
have shown it is a potent stimulator of IL-8 and IL-6 in CFBE41o- cells (Kaza et al., 
2010). The host response to PalBc requires more investigation to further examine its 
role in inflammation and the signalling pathways involved in the response to Pal.    
Pal is generally regarded as an outer membrane periplasmic protein and was 
not previously associated with a role in host cell attachment. We clearly show that 
Bcc Pal is involved in the attachment of Bcc to lung epithelial cells, with the Δpal 
mutant cells showing reduced ability to bind to lung epithelial cells, which was 
reversed in the complemented strain. Furthermore, recombinant E. coli expressing the 
complete PalBc transcript showed enhanced attachment to CF lung cells, indicating 
that Bcc Pal can directly mediate the attachment of Bcc to the host epithelium. MS 
analysis showed that PalBc is expressed in its lipidated form and while it was purified 
from cell lysates via its His-tag, a quantity of the expressed protein is likely to be 
cleaved following lipidation and transported through the inner membrane. Other 
lipoproteins are involved in facilitating host cell adhesion, for example an outer 
membrane lipoprotein, from Moraxella catarrhalis, which shares 58% homology with 
P. aeruginosa LppL, is important in the attachment of M. catarrhalis to human 
respiratory tract cells (de Vries et al., 2013). Pal has a conserved surface-exposed 
epitope in H. ducreyi (Spinola et al., 1994) and more recently was reported to be 
surface expressed in a subpopulation of E. coli cells (Michel et al., 2015). Given the 
similarities between Bcc and E. coli Pal shown here, it is highly likely that Pal can 
also be partially expressed at the surface of Bcc cells, mediating the direct interaction 
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between Bcc and host epithelial cells. The membrane localisation of PalBc would need 
to be confirmed experimentally and is the basis of future work.  
Pal was among a group of genes that were induced in vivo in a chronic 
respiratory infection model, suggesting that it contributed to bacterial adaptation and 
survival in the lungs (O'Grady and Sokol, 2011). We have recently shown that  
attachment to CF epithelial cells was enhanced over time of chronic colonisation in a 
series of sequential clinical B. cenocepacia isolates (Cullen et al., accepted 
manuscript), therefore the observed induction of Pal in the chronic rat infection model 
complements our findings as it suggests that Pal may contribute to the enhanced host 
cell attachment observed in the clinical chronic infection isolates and its expression 
may contribute to successful colonization of the host. The involvement in host cell 
attachment is also consistent with findings that a lipoprotein, which subsequently 
showed  95.8% identity to the Pal encoded by BCAL3204, was the immunodominant 
antigen in Bcc infected mice  (Makidon et al., 2010, O'Grady and Sokol, 2011).   
In summary, this study demonstrates that PalBc is structurally similar to Pal 
proteins in other Gram-negative bacteria, is involved in peptidoglycan binding and 
can mediate host cell attachment to epithelial cells. More importantly, PalBc is a 
strong stimulator of IL-8 secretion, becoming a major contributor to inflammation in 
the lung with comparable potency to LPS.  
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Experimental Procedures  
Bacterial strains   
B. cenocepacia K56-2 was obtained from the BCCM/ LMG, University of Ghent, 
Belgium and was routinely plated onto Burkholderia cepacia selective agar (BCSA) 
(Henry et al., 1997). Bacteria were grown in Luria Bertani (LB) broth at 37 °C with 
orbital agitation (150 rpm). The growth rate of wild type and mutant strains was 
determined in LB broth at 37 °C over 7 h. Samples were taken every 30 min and 
plated on LB agar.  Colonies were counted and plotted against time of sampling to 
determine the generation time. 
 
Culturing epithelial cells   
The CFBE41o- lung epithelial cell line, which is homozygous for the CFTR ΔF508 
mutation, the most commonly inherited CF mutation, was a gift from Dr. Dieter 
Gruenert (UCSF California).  CFBE41o- cells were maintained in MEM medium with 
10 % (v/v) FBS, 1 % penicillin/streptomycin, 1 % L-glutamine and 1 % non-essential 
amino acids and incubated in 5 % CO₂ environment at 37 °C.  
 
Mutagenesis of B. cenocepacia K56-2 and complementation  
Unmarked and non polar mutations were performed by the protocol of Flannagan et 
al. (Flannagan et al., 2008). The amplicons to construct the mutagenic plasmid were 
digested with EcoRI-HindIII and HindIII-NheI, respectively, and cloned into pGPI-
SceI-2 digested with EcoRI and NheI. Once introduced by conjugation into B. 
cenocepacia K56-2, the mutagenic plasmid integrates into the chromosome, giving 
rise to trimethoprim-resistant exconjugants. A second plasmid, pDAISce-I, encoding 
the I-SceI endonuclease was then introduced by conjugation resulting in double-
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strand breaks in the chromosome at the Sce-I recognition site. The deletion of pal 
(BCAL3204) was first analyzed by PCR and then confirmed by DNA sequencing. To 
complement B. cenocepacia K56-2 Δpal, wild-type pal was PCR amplified from B. 
cenocepacia K56-2 (see primers in Table 2). The resulting amplicon was digested 
with NdeI and XbaI and ligated into a similarly digested pMH447 vector. The 
complementation plasmid was introduced into the mutant by conjugation. Once 
transferred into the target mutant strain the complementation vector integrates into the 
genome at aminoglycoside efflux pump genes (BCAL1674-BCAL1675), due to 
sequence homology between the vector and target genome (Hamad et al., 2010). As 
before, pDAISce-I was introduced resulting in the replacement of BCAL1674-1675 
by pal. The correct replacement was confirmed by PCR amplification.   For virulence 
studies, the pal gene was also complemented using a plasmid constitutively 
expressing wild-type K56-2 pal which was constructed by amplifying the gene 
(primers in Table 2). Amplicons were digested with NdeI and XbaI and cloned into a 
similarly digested pDA12 vector, resulting in pDA12-pal.  These complements are 
designated Δpal(pDA-12pal).  
 
G. mellonella survival assay   
Log growing bacteria were diluted to OD600 0.1 in sterile PBS and serially diluted to 
10-7. Each dilution (20 µl) was injected into the hindmost left proleg of G. mellonella 
larvae using a sterile Terumo 0.3 ml syringe (10 larvae per group). An equal volume 
of each dilution was also plated onto LB agar and plates were counted at 48 h to 
accurately quantify bioburden injected. Ten larvae injected with PBS alone served as 
controls. Larvae were incubated at 37 °C and examined for survival at 24, 48 and 72 
h. The % larval survival was plotted against the colony forming units (CFU) 
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inoculated value to calculate the LD50 value for each strain (Costello et al., 2011). 
Cell-free supernatants of K56-2 wild-type and mutants were also assessed by 
centrifuging overnight cultures at 2,500 g for ten min. The supernatants were 
decanted into a sterile universal and filter-sterilised using a 0.20 µm filter to obtain 
cell-free supernatant. Aliquots (20 µl) of each supernatant were injected into groups 
of larvae and 20 µl of supernatant was also plated onto LB agar to ensure sterility. 
Ten larvae injected with LB broth alone, served as controls. In separate experiments, 
recombinant purified endotoxin free Pal was also injected into groups of larvae and 
compared with negative control and with LPS.  Larval survival was examined at 24, 
48 and 72 h post-inoculation and % survival relative to LB control group determined 
each time point. 
 
Accumulation of fluorescent dye H33342 
Cellular permeability was determined by uptake of fluorescent dye H33342 as 
previously described (Coldham et al., 2010). Overnight cultures were used to 
inoculate fresh medium and cultured for a further 5 h at 37 oC. The cells were 
centrifuged at 4000 g and resuspended in 1 ml PBS and OD600nm adjusted to 0.1, 
before transferring to 96-well plates. Strains were aliquoted in replicates of eight with 
8 control replicates (PBS only) and the plate transferred to a BioTek Synergy H1 
Hybrid reader and incubated at 37 oC.  H33342 (100 µM) was added to each well to 
give a final concentration of 10 µM. This optimal concentration was determined in 
preliminary optimisation studies comparing the fluorescence discrimination between 
Δpal mutant and wild-type at 2.5, 10 and 100 µM H33342. Plates incubated for 90 
min with fluorescent readings taken every minute (λex = 355 nm, λem = 460 nm). 
Raw fluorescence values were analysed by determining the mean of 8 replicates, 
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subtraction of the relevant control fluorescence at each time point and zero time point 
fluorescence to normalise for starting fluorescent value.   
 
Cloning and expression of PalBc   
The forward primer was designed to contain the CACC sequence at the beginning of 
the primer to introduce a 5’ overhang allowing directional cloning of the BCAL3204 
(pal) gene into pET100/D-Topo (Thermo Fisher, Paisley, UK) (in-frame with a 35-
amino acid tag construct containing the N-terminal 6xHis tag and Xpress epitope. 
PCR amplification was carried out using HotStar Taq polymerase (Qiagen) and 
amplicons cloned into the pET100/D-Topo according to the manufacturer’s protocol. 
The TOPO® cloning reaction was added to a vial of One Shot® TOP10 Chemically 
Competent E. coli and cells heat-shocked for 30 sec at 42°C without shaking. Each 
transformation reaction was spread on to pre-warmed selective plates containing 50 
µg/ml of ampicillin and incubated overnight at 37°C. Positive transformants were 
identified using PCR. BL21 Star™ (DE3) One Shot® cells were used for protein 
expression. After confirming PalBc expression in a pilot study, 1 L cultures of BL21 
cells transformed with the expression plasmid were grown in LB broth with 
ampicillin (100 µg/ml) and expression induced with IPTG at a final concentration of 1 
mM for 3 h at 37 °C. Bacteria were then pelleted using centrifugation at 2,500 g for 
10 min. Supernatants were discarded, pellets weighed and stored at -80 °C. 
 
PalBc purification  
Purification of PalBc was carried out as described by Franken et al. (Franken et al., 
2000) with some modifications to ensure complete removal of lipopolysaccharide 
from the preparation. Ice-cold lysis buffer containing 6 M Guanidine-HCL, 100 mM 
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sodium phosphate, 10 mM Tris-HCl (pH 8) and 1X EDTA-free protease inhibitor was 
added to bacterial pellets at a volume of 30 ml corresponding to 7 g of wet cell pellet. 
Cells were resuspended in lysis buffer by vortexing and pipetting and subsequently 
lysed on ice with a cell disruptor using maximum output for two 30-sec pulses. Cell 
debris and any remaining intact cells were pelleted using centrifugation at 6,300 rpm 
for 35 min. Supernatants were filtered through a 0.45 µM filter and incubated with a 
rotating Ni-NTA column, which was pre-equilibrated with buffer A, for 1 h at 4 °C. 
Unbound protein and endotoxin were removed from the column by a series of washes 
with 8 M Urea in phosphate buffer, followed by two rounds of organic washes (60% 
isopropanol in 10 mM Tris HCl) alternating with 10 mM Tris HCl. Bound protein was 
subsequently eluted with 1 % trifluoroacetic acid followed by two additional elution 
steps in 250 and 300 mM imidazole. After purification, the protein concentration of 
each fraction was determined using the Bradford assay. Protein purity was determined 
by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). 
Proteins were concentrated using Amicon® filters with a 3 kDa cut-off, resuspended 
in 50 mM Tris (pH 7) and tested for endotoxin content by the Limulus amebocyte 
lysate (LAL) assay using the ToxinSensor Gel clot endotoxin assay kit (Genscript, 
New Jersey) according to the manufacturer’s instructions.  The mass of the intact 
purified protein was confirmed by Electron spray Mass Spectroscopy (Alta 
Biosciences, Birmingham, UK).  
 
Cloning, expression and purification of truncated Pal51-170  
Bioinformatic analyses were carried out using SignalP, LipoP, XtalPred (Jahandideh 
et al., 2014, Bendtsen et al., 2004). Based on these analyses, the variant with the 
highest crystallization success rate was a Pal protein lacking the first 50 N-terminal 
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amino acids (Pal51-170).  A DNA fragment encoding Pal51-170 was obtained by PCR 
amplification (primers shown in Table 2). The amplicon was subcloned into the 
pETM13 expression system to obtain a C-terminal 6xHis-tag recombinant protein and 
introduced into E. coli BL21(DE3) by transformation. Overnight cultures were 
inoculated in 1 L LB supplemented with kanamycin (50 µg/ml), and incubated at 
37°C with 180 rpm shaking until the OD600nm reached 0.65. Optimal Pal51-170 
expression was obtained using 0.8 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) 
at 22°C for 16 h.  Harvested bacterial cells were resuspended in lysis buffer (50 mM 
Tris-HCl, 300 mM NaCl, 5% Glycerol, 0.01% CHAPS, 10 mM Imidazole, pH 7.5) 
supplemented with a protease-inhibitor cocktail (Roche Diagnostic).  After sonication 
and subsequent centrifugation at 30,000 g for 30 min, the soluble fraction was 
purified by affinity chromatography using a 5 mL Ni-NTA column (GE Healthcare). 
After washing with Binding Buffer (50 mM Tris-HCl, 300 mM NaCl, 5% Glycerol, 
0.01% CHAPS, pH 7.5), Pal51-170 was eluted with a linear gradient of Imidazole (5-
300 mM) and the fraction collected was analysed by SDS-PAGE. A final purification 
step by size exclusion chromatography was performed using S75 10/300 (GE 
Healthcare) column in 50 mM Tris-HCl, 150 mM NaCl, 5% Glycerol, pH 7.5. The 
eluted fractions were concentrated using Amicon ultra column (Millipore) at a final 
concentration of 30 mg/ml for crystallization experiments, resulting in a protein of 
14894.1 Da as calculated by mass spectrometry. 
 
Extraction and analysis of LPS   
Stationary-phase cultures (500 ml) of K56-2 wild-type and Δpal mutant strains were 
centrifuged at 4,000 rpm for 10 min to pellet bacteria and each pellet weighed. Pellets 
were then washed with endotoxin-free water, pelleted again and resuspended in 10 ml 
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of endotoxin-free water. Bacteria were disrupted by sonication in ice-cold water for 
10 min. Bacterial lysates and a 90% phenol solution were equilibrated at 65 °C before 
the addition of 10 ml of the phenol solution to the lysates (Davis and Goldberg, 2012) 
for a further 50 min at 65 °C with regular vigorous shaking. Lysates were 
subsequently incubated on ice for 20 min before centrifugation at 2,500 g for 25 min 
at 4 °C to separate aqueous and phenol fractions. The aqueous layer was carefully 
removed and placed in a fresh 50 ml tube. The phenol layer was placed back in the 65 
°C water bath and 10 ml of water pre-heated to 65 °C was added. Tubes were 
incubated for a further 30 min with vigorous shaking as before, cooled and 
centrifuged and the aqueous layer retained. Aqueous fractions, containing LPS, were 
placed in pre-equilibrated dialysis tubing (3.5 kDa cut-off) and tubing placed in 2 L 
beakers containing ultrapure water. Dialysis was carried out at 4 °C over 4 days, with 
water changed twice daily, to ensure the complete removal of phenol. Dialysed 
fractions were placed into separate round-bottomed flasks and lyophilised overnight. 
Lyophilised crude LPS was removed carefully from round-bottomed flasks, placed 
into sterile tubes and weighed. LPS extracts were resuspended in endotoxin-free water 
to a final concentration of 1 mg/ml. LPS from both strains was analysed on 15 % 
acrylamide gels. 
 
Effect of purified Pal and LPS on G. mellonella survival 
Purified endotoxin-free PalBc was reconstituted in 50mM Tris buffer (400µg/ml) and a 
range concentrations (12.5 to 150µg/ml) were injected into groups of larvae (10 
larvae per group) in an injection volume of 20µl.    Larvae were injected with 50 mM 
Tris buffer alone or either 150 and 1000µg/ml LPS as controls.  Aliquots of 20 µl of 
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each purified protein and LPS were also plated onto LB-agar for 48 hours to 
determine if there was any bacterial contamination. 
 
Attachment of bacteria to epithelial cells     
To quantify the attachment of either B. cenocepacia or PalBc-expressing E. coli strains 
to lung epithelial cells, CFBE41o- cells were seeded in coated chamber slides 24 h 
prior to the 30 min incubation of individual bacterial strains at an MOI of 50:1, as 
previously described (McClean et al., 2016). In the experiments with recombinant E. 
coli strains, expression was induced with 1 mM IPTG for 3 h prior to incubation with 
epithelial cells. Unattached bacteria were removed by washing with sterile PBS four 
times for five min each. Attachment was quantified by lysing the cells with 0.5% 
Triton X for 20 min, scraping the cells to remove them, serially diluting in PBS and 
plating on LB agar plates. Plates were incubated at 37 °C and CFU were counted after 
48 h. Attachment was also confirmed by confocal microscopy after fixing the 
CFBE41o- cells in 3 % paraformaldehyde (pH 7.2) for 10 min at room temperature. 
Cells were gently washed once with PBS and then blocked in PBS containing 5% 
bovine serum albumin for one hour at room temperature. Cells were incubated 
overnight at 4 °C in PBS containing 1 % bovine serum albumin and either rabbit anti-
Bcc (1:800 dilution) or FITC-conjugated anti-E. coli antibodies (1:100 dilution). In 
the case of B. cenocepacia strains, the next day cells were washed three times with 
PBS before the addition of FITC-conjugated anti-rabbit antibody (1:500 dilution) for 
one hour in the dark. The secondary antibody was removed and cells washed twice for 
five min each with PBS. Cells were then counterstained with DAPI and phalloidin 
conjugated to Alexa fluor 568 (5U/ ml) for 15 min in the dark at a concentration of 1 
µg/ml in PBS to highlight the nuclei and intracellular area via staining of actin 
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filaments with the cytoplasm, respectively. A coverslip was applied to each chamber 
before bacteria and cells were visualised using confocal microscopy. Bacterial 
attachment was counted in 20 randomly selected fields for each strain, in three 
independent experiments and values were expressed as the number of bacteria/100 
cells. 
 
Cytokine analysis   
CFBE41o- cells were seeded overnight in antibiotic-free medium in 24-well plates at 
a density of 4 x 105 cells/well and subsequently the medium was replaced with 
antibiotic free and serum-free medium, and cells incubated overnight. The next day 
bacteria were incubated with CFBE 41o- cells at an MOI of 50:1 at 37 °C in 5 % CO₂ 
environment for 24 h. Alternatively, CFBE41o- cells were incubated with PalBc 
protein (10-100 µg/ml) for 24 h, purified LPS from K56-2 (100 µg) or MEM alone; 
the latter two served as positive and negative controls, respectively. The next day, 
plates were centrifuged at 1,500 g for 10 min and supernatants retained and stored at -
80 °C. Cytokine analysis was performed using the MesoScaleDiscovery (MSD, 
Gaithersburg, MD, USA, www.mesoscale.com) Multispot system. For this, cell 
supernatants were diluted 1 in 5 with MEM and then an equal volume of Diluent was 
added. The 4-plex multi-array electrochemiluminescence platform (detection range 
0.008 ng/ml to 1000 ng/ml, i.e. factor 125000) was used to measure ten cytokines 
(IFNγ, IL-10, IL12p70, IL-13, IL-1β, IL-2, IL-4, IL-6, IL-8, TNFα) simultaneously in 
cell supernatants. This system uses multi-array plates fitted with multi-electrodes per 
well with each electrode being coated with a different capture antibody. Each sample 
was analyzed in duplicate on the same array plate. Samples and calibrator solutions 
were added to plates coated with cytokine-specific capture antibodies and incubated 
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overnight at 4 °C before washing 3 times with 100 µl of PBS containing 0.05 % 
Tween-20. The nine detection antibodies (120 µl each) were combined at a final 
volume of 6 ml; 25 µl of the mixture were added to each well and incubated with the 
plate for 1 h. Wells were washed three times with PBS containing 0.05 % Tween-20 
(100 µl), before reading on the MSD plate reader. 
 
Circular Dichroism spectroscopy   
Circular dichroism measurements were carried out using a Jasco J-810 
spectropolarimeter equipped with a Peltier temperature control system (Model PTC-
423-S). The molar ellipticity per mean residue, [θ](deg cm2 x dmol-1),  was calculated 
from the equation [θ] = [θ]obs x mrw x (10 x l x C)-1, where [θ]obs is the ellipticity 
measured in degrees, mrw is the mean residue molecular mass (105.3 Da), C is the 
protein concentration in g x l-1  and l is the optical path length of the cell in 
centimetres. Far-UV spectra (190–260 nm) of Pal51-170 were recorded at 293K using a 
0.1 cm optical path-length cell, with a protein concentration of 0.2 mg/ml. For thermal 
denaturation experiments, ellipticity was monitored at 222 nm with a temperature 
slope of 1°C/min from 20°C to 100°C. Melting temperature was calculated from the 
maximum of the first derivative of the unfolding curves. 
 
Sequence conservation analysis   
Sequence conservation analysis was carried out using ConSurf (Goldenberg et al., 
2009). The homologue search algorithm CSI-BLAST was used to retrieve sequences 
from the UNIREF-90 sequence database using an E-value cut-off of 0.001. Sequences 
were aligned using MAFFT-L-INS-I alignment method (Katoh and Standley, 2013). 
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Light Scattering Analysis   
Purified Pal51-170 was analyzed by size exclusion chromatography coupled with light 
scattering using a DAWN MALS instrument and an Optilab rEX (Wyatt 
Technology). Eight hundred micrograms of purified Pal51-170 were loaded into a S75 
16/60 column (GE Healthcare), equilibrated in 50 mM Tris-HCl, 150 mM NaCl, 5% 
Glycerol, pH 7.5. The on-line measurement of the intensity of the Rayleigh scattering 
as a function of the angle, as well as the differential refractive index of the eluting 
peak in size exclusion chromatography, was used to determine the weight average 
molar mass (Mw) of eluted protein, using the Astra 5.3.4.14 (Wyatt Technologies) 
software. 
 
Isothermal Titration Calorimetry 
ITC experiments were performed at 295 K using a high-sensitive titration calorimeter 
system (MicroCal iTC200, Malvern, UK) with a reference power of 8 cal/s and a 
stirring speed of 1000 rpm. To remove	endogenous peptidoglycan fragments, purified  
Pal51-170 was extensively dialyzed in a denaturing buffer (4 M GuHCl, 25 mM Tris-
HCl and 150 mM NaCl, pH 7.5) at room temperature for 16 h and then refolded in 25 
mM Tris-HCl, 200 mM NaCl and 0.005 % (v/v) CHAPS, pH 7.5) for 3-4 days. 
Ligand sample was dissolved in the dialysis buffer. For the ITC measurements, the 
dipeptide iE-DAP was purchased from InvivoGen (San Diego, CA, USA). Titration 
experiments consisted of additions of 19 injections with 2 µL of ligand (2 mM) to the 
protein solution contained in the cell (0.27 mL of 0.1 mM of Pal51-170) with 150-s 
equilibration between injections. Data were analyzed with Origin 5.0 software 
(MicroCal) with a single-site model.  
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Crystallization of Pal51-170.   
Crystallization trials were performed using hanging drop vapour diffusion technique 
at 293K. Preliminary crystallization trials were performed using a robot station 
(Hamilton STARlet NanoJet 8+1) for high throughput crystallization screening with 
commercially available sparse matrix kits (Crystal Screen kit I e II, Index, PEG/ION, 
Hampton Research). Optimization of crystallization conditions was performed 
manually using the additive Hampton screening. The best crystals were obtained at a 
protein concentration of 30 mg/ml in 0.1M bis[2-Hydroxyethyl]imino-
tris[hydroxymethyl]methane pH 5.5, 25% w/v Polyethylene glycol 3350, 10 mM 
MgCl2. Cryoprotection of the crystals was achieved by a fast soaking in a solution 
containing glycerol to a final concentration of 25% (v/v). The data sets were scaled 
and merged using HKL2000 program package. Statistics of data collection are 
reported in Table 3. The crystal structure was solved by Molecular Replacement using 
the software Phaser (McCoy et al., 2007), and the structure of acute phase antigen 
BPSL2765 from B. pseudomallei as a template (Gourlay et al., 2013). 
Crystallographic refinement was first carried out against 95% of the measured data 
using the CCP4 program suite (Potterton et al., 2003). The remaining 5% of the 
observed data, which were randomly selected, was used in Rfree calculations to 
monitor the progress of refinement. The structure was validated using PROCHECK 
(Laskowski et al., 1996). Coordinates and structure factors were deposited with the 
Protein Data Bank with the PDB code 5LKW. 
 
Analysis of Lipid A   
Overnight cultures in 100 ml of LB were washed twice with phosphate buffer (pH 
7.4) and freeze dried. Lipid A was extracted by resuspending lyophilized bacterial 
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cells (10 mg) in a mixture of isobutyric acid:1 M ammonium hydroxide (400 µl, 5:3, 
v/v) and heating at 100°C  for 2 h with vortexing every 15 min, and then centrifuged 
at 2000 g for 15 min. The supernatant was mixed with an equal volume of water and 
lyophilized. The sample was washed with methanol twice and lipid A was solubilized 
in 80 µl of chloroform:methanol:water (3:1.5:0.25, v/v, 80 µl)  for 4 h. Lipid A 
suspension was desalted with grains of ion-exchange resin (Dowex 50W-X8; H+). 
Desalted lipid A suspension (2 µl ) was loaded on polished steel target, air dried and 
covered with 1 µl of 2,5-dihydroxybenzoic acid matrix (Sigma Chemical Col, St. 
Louis, MO) dissolved in 0.1 M citric acid aqueous solution and allowed to dry. The 
target was inserted in a Bruker Autoflex MALDI-TOF spectrometer. Data acquisition 
and analysis were performed using the Flex Analysis software. 
 
Statistical analysis    
Statistical analysis of cytokine release and Bcc attachment to epithelial cells was 
carried out using one-way ANOVA followed by Bartlett’s test, using GraphPad 
Prism. Comparison of attachment of E. coli BL21 Star cells expressing or not 
expressing Bc Pal was performed by one-way ANOVA using Minitab software.   
Comparison of the fluorescent dye accumulation curves was performed by two-way 
ANOVA using GraphPad Prism.  Log-Rank test of survival data were performed 
using the GraphPad Prism software version 6.0 (GraphPad Software, San Diego 
California) ****P<0.001.   
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Table 1: Strains and plasmids used in this study 
Strain or 
plasmid 
Characteristics Origin 
B. cenocepacia    
K56-2 
(LMG18863) 
ET12 clone related to J2315, cystic fibrosis isolate BCRRC, CF 
clinical isolate 
Δpal  Deletion of pal (BCAL3204) in K56-2 This study 
Δpal(pal+)    Chromosomal pal integration in K56-2 Δpal This study 
Δpal(pDA-
12pal) 
Plasmid complemented on pDA-12 plasmid This study 
   
E. coli   
NCIB9485 Strain B/r Laboratory 
collection 
GT115 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80ΔlacZΔM15 
ΔlacX74 recA1 rpsL (StrA) endA1Δdcm uidA 
(ΔMIuI)::pir-116 ΔsbcC-sbcD 
Invitrogen 
SY327 araD Δ(lac pro) argE(Am) recA56 nalA λpir; RifR (Miller and 
Mekalanos, 
1988) 
DH5α F- ϕ80dlacZΔM15 Δ(lacZYA-argF)U169 endA1 recA1 
hsdR17(rK - mK +) supE44 thi-1 ΔgyrA96 relA1 
Laboratory 
collection 
Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacΧ74 recA1 araD139 Δ(ara-leu)7697 galU galK 
rpsL (StrR) endA1 nupG  
Invitrogen 
BL21 StarTM 
(DE3) 
F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3)  Invitrogen 
   
Plasmids   
pGPIScel-2 oriR6K, ΩTpR , mob+, containing the ISce-I restriction 
site 
(Flannagan et al., 
2008) 
pRK2013 oriColE1, RK2 derivative,  KanR, mob+, tra+ (Figurski and 
Helinski, 1979) 
pDAI-SceI Encodes the ISce-I homing endonuclease, TetR (Flannagan et al., 
2008) 
pMH447 pGPI-SceI derivative used for chromosomal 
complementation 
(Hamad et al., 
2012) 
pDA12 oripBBR1, TetR, mob+, Pdhfr used for plasmid 
complementation 
(Aubert 2008) 
pET100/D-
Topo 
Peptide fusion at N-terminal, 6xHis, AmpR Invitrogen 
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Table 2.   Primers used in this study   
Region: 5’-3’ primer sequence: Product size 
(bp) 
Restriction 
enzymes: 
Upstream actgacgaattctggcggtgcgccacagatcta  
tgatataagcttattgtttgccttgtcgtcgag 
513 EcoRI HindIII 
Downstream tcaattaagcttgaagccgtgagcctcggcaa 
agtgatgctagcctctgcggatacttcgcgatg 
612 HindIII   NheI 
Complementation ttttcatatgatgtcgaataaagctcgt 
gttttctagattactgttggtagacgag 
533 NdeI    XbaI 
Internal ttcggtgaaggacgagtacc  
cacggcttccatttgagaat  
205 N/A 
Cloning caccatgatgtcgaataaagct  
cgttacttactgttggtagac 
526 N/A 
Pal51-170 catgccatgggcgtcgatccgctgaacgacc  
gatgctcgagctgttggtagacgaggtcg 
382 N/A  
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Table	3.	Structural	data	collection	and	refinement	statistics.	Values	in	parentheses	are	for	the	highest	resolution	shells	2.15-2.00	Å. 	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
†Rmerge= Σ hΣi |I(h,i)-<I(h)>|/ Σ hΣi I(h,i), where I(h,i) is the intensity of the ith 
measurement of reflection h and <I(h)> is the mean value of the intensity of reflection h.  
Data collection  Apo	 	
Space	group	 P32	 	
Unit-cell	parameters	a,	b,	c	
(Å),	γ 	(°)	
77.7,	77.7,	38.6,	120					 	
Resolution	range	(Å)	 30.0-2.0		 	
Wavelength	(Å)	 		1.542	 	
Mosaicity	(°)	 0.5	 	
Average	redundancy	 5.5	(5.4)	 	
Unique	reflections	 14094	 	
Completeness	(%)	 100.0	(100.0)	 	†Rmerge	(%)	 8.4	(43.8)	 	
Average	I/σ(I)	 4.9	(3.2)	 	
 	 	
Refinement 	 	
Resolution	range	(Å)	 15.0-2.0	 	
Rwork/Rfree	(%)	 19.4/24.2	 	
No.	of	residues	 240	 	
No.	of	water	molecules		 176	 	
R.m.s.	deviations	 	 	
Bond	lengths	(Å)	 0.01	 	
Bond	angles	(°)	 1.5	 	
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Figure Legends    
 
Fig. 1. Pal plays a role in bacterial membrane integrity.      
A.  Genetic organization of the gene cluster encoding Pal and Tol proteins in B. 
cenocepacia J2315 and K56-2. Grey arrows indicate the direction of transcription of 
each gene. BCAL gene designations are according to annotation of the B. 
cenocepacia J2315 genome (http://www.sanger.ac.uk/Projects/B _cenocepacia/).   
B.  Survival of G. mellonella after 72 h exposure to supernatants from K56-2 wild-
type (●) and Δpal mutant (■) and complemented strain Δpal(pal+) (▲).  * P<0.0001, 
Log Rank (Mantel-Cox) test comparison between the virulence of K56-2 wild-type 
and Δpal mutant. 
C. Effect of Pal on membrane permeability. Accumulation of H33342 fluorescent dye 
was examined in the Δpal mutant, complement and wild type K56-2 cells over 90 
minutes. 
 
Fig. 2. Pal does not affect LPS structure but is involved in polymyxin resistance.  
A.  Effect of Pal on LPS structure.  Extracted LPS from K56-2 wild-type and the Δpal 
mutant strain. Lane 1: wild-type LPS. Lane 2: Δpal mutant LPS. Samples were run on 
a 15 % acrylamide gel and stained with silver stain.   
B.  Mass spectrometry of lipid A from wild-type K56-2 and the Δpal mutant.  Lipid A 
was extracted from bacteria, desalted with ion-exchange resin, loaded on polished 
steel target, with 1 µl of 2,5-dihydroxybenzoic acid matrix before analysis on a 
MALDI-TOF mass spectrometer. Data acquisition and analysis were performed using 
the Flex Analysis software. 
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  Fig. 3. Pal is a lipoprotein with a stable α-β conformation.   
A.  Domain organization of PalBc according to the Pfam database. The signal peptide 
(SP) and cleavage site were predicted by Signal P 4.1 and LipoP 1.0 servers, 
respectively. 
B.  Gel filtration profile of Pal51-170 along with the SDS PAGE analysis of main 
fractions. Pal51-170 was eluted from a Ni NTA column with an Imidazole gradient and 
fractions collected were analysed by SDS PAGE.   
C.  Size exclusion chromatography-multi angle light scattering analysis; the grey 
curve represents the Rayleigh ratio (left scale) against the elution time. Molecular 
mass values (Mw, right scale), corresponding to a monomeric state, are reported in 
black. 
D.  CD spectrum of Pal51-170 measured on a spectropolarimeter equipped with a Peltier 
temperature control system.  Molar ellipticity per mean residue was calculated in the 
far UV range at 293 K with a protein concentration of 0.2 mg/ml.  
E.  Thermal denaturation of Pal51-170 achieved by following the CD signal at 222 nm 
as a function of temperature.   
 
Fig. 4.  Structural determination of Pal51-170  
A.  Ribbon representation of Pal51-170 crystal structure (chain A).  The α helices and β 
strands are marked.   
B.  Molecular surface of Pal51-170 (green) highlighting the cavity; Arg-120 is coloured 
blue.   
C.  Degree of residue conservation on the protein surface (Consurf analysis). Residue 
coloring, reflecting the degree of residue conservation, ranges from magenta (highly 
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conserved) to cyan (variable). The most conserved residues lining the cavity are 
labelled.  
D.  Omit (Fo-Fc) electron density map contoured at 2.0 σ of the DAP moiety in the 
cavity. H-bonding interactions are indicated with dashed lines. 
 
Fig. 5. Isothermal titration calorimetry confirmed that Pal51-170 can bind to DAP.   
A.   Raw data for the titration of Pal51-170 with iE-DAP (inset).  Binding isotherms 
were measured at pH7.5 and showed exothermic heats of binding that decreased with 
each successive injection of iE-DAP up to a point of saturation.  
B.   Integrated heats of binding obtained from the raw data, after subtracting the heat 
of dilution. The solid line represents the best curve fit to the experimental data, using 
the single site model from MicroCal Origin. 
 
Fig. 6.  PalBc stimulates cytokine secretion from CF epithelial cells.  
Cytokine secretion was measured after exposure of CFBE41o- cells to wild-type K56-
2, Δpal mutant strain or PalBc, as determined by multi-array electrochemi-
luminescence.  
A and B.  IL-8  (A) and IL-6 (B) secretion from CFBE41o- cells after incubation with 
wild-type K56-2, Δpal mutant, purified LPS or medium alone. Error bars represent 
the standard deviation of three independent biological repeats, ***p<0.001 relative to 
wild-type.    
C and D.  IL-8 (C) and IL-6 (D) secretion in response to increasing concentrations of 
PalBc (10-100 µg/ml) compared to LPS (100 µg/ml) or medium alone (control). Error 
bars represent the standard deviation of three independent biological repeats. *p<0.05, 
**p<0.01, ***p<0.001 relative to the medium-only control 
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Fig. 7.  PalBc  is involved in CF epithelial cell attachment.    
A.  Attachment of K56-2, Δpal mutant and E. coli NCIB 9485 control strain to 
CFBE41o- cells determined by CFU/ml after incubation of epithelial cells with the 
strains at an MOI 50:1. Error bars represent the standard error of the mean (SEM) 
from 4 independent experiments. * p<0.05, compared with the attachment of K56-2 
wild-type.  
B.  Confocal microscopy images confirming the attachment of wild-type, Δpal mutant 
and Δpal(pal+)complemented strains to CFBE41o- cells. Bacteria were labelled using 
a primary anti-Bcc antibody and detected with a secondary FITC-conjugated 
polyclonal antibody (green). CFBE41o- cells were counterstained with DAPI (blue). 
*P<0.05.  C.  Quantification of attachment from confocal microscopy. Graph 
represents B. cenocepacia attachment to CFBE41o- cells, using an MOI 50:1. Data 
represents the number of bacteria/100 cells for each strain. Error bars represent the 
standard error of the mean (SEM) from 3 independent experiments.  *P<0.05 
 
Fig. 8.  E. coli expressing PalBc showed increased attachment over E. coli wild type.   
A.  Representative confocal microscopy images representing the attachment of E. coli 
BL21 control and E. coli BL21(pET100/D-Topo) strain expressing PalBc  to 
CFBE41o- cells. Bacteria were labelled using a FITC-conjugated primary anti-E. coli 
antibody (green). Nuclei of CFBE41o- cells were counterstained with DAPI (blue) 
and actin stained with phalloidin conjugated with Alexa fluor 568.  
B.  Quantitation of the attachment of E. coli BL21 control and E. coli 
BL21(pET100/D-Topo) strain expressing PalBc  attachment to CFBE41o- cells, using 
an MOI 50:1. Data represents the mean number of bacteria/ 100 cells for each strain 
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determined by counting 20 individual fields per strain in each of three experiments.  
Error bars represent the standard error of the mean (SEM) from three independent 
experiments,  *P<0.0001. 
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Supplementary figures:  
Fig.  S1 
Polymyxin B and meropenem sensitivities of wild-type K 56-2, Δpal mutant and 
Δpal(pal+) strains as determined by E-test strips (polymyxin 0.064-1.024µg/ml; 
meropenem 0.002=31µg/ml.  Images are representative of three independent 
experiments.    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Polymyxin 
Meropenem 
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Fig.	S2	:	Expressed	PalBc	highlighting	polyHis	tag,	Xpress	epitope,	signal	peptide	and	lipobox.				
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDHPFT MMSNKARLALAV
MMISALAACKSGVKLDDKANNAGAVSTQPSADNVAQVNVDPLNDPNSPLA
KRSIYFDFDSYSVKDEYQPLMQQHAQYLKSHPQRHVLIQGNTDERGTSEYNL
ALGQKRAEAVRRAMALLGVNDSQMEAVSLGKEKPQATGHDEASWAQNRR
ADLVYQQ
Predicted	molecular	mass:	22815.41	Da
Polyhistidine
region Xpress	epitope
Lipobox
Signal	peptide
Signal	peptide
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Fig.	S3:		PalBc	identified	as	a	palmitoylated,	dimyristated	and	dilaurylated	forms	and	in	unacylated	form.				 Expected	mass	
(+/-	5da)	
Observed	mass		PALBc	(with	His-tag	and	Xpress	epitope)		 22815.41	 22820.0	DAP	residue	 190.2	 Not	found	+DAP	+	dilaurylate	 23412.04	 23408.0	+DAP	+	dimyristate	 23467.54	 23460.0	+DAP	+	dipalmitate	 23520.22	 23520.0			
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Fig. S4.  DAP incorporation into the cavity of Pal51-170.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAP 
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Fig. S5.   Structural organization of the residues interaction with Pal51-170 
